In medical practice, anesthesia is a state of body, induced by drugs
to suppress sensations which are called as anesthetics. Anesthetic
agents act on the central nervous system altering the motor function
of neurons. Anesthesia is employed during major and minor surgeries
to ease the procedure for surgeon and patient. Anesthetic agents can
be administered intravenously, subcutaneously, orally, or by
inhalation. Various inhalation anesthetics have been in use for a
long time such as chloroform, chloroethane, and diethyl ether.
Inhalation anesthetics are used to induce and maintain general
anesthesia while performing surgical procedures. Inhalation
anesthetic agents are administered through masks or tracheal tubes.
These agents get perfused into blood though alveoli and transported
to central nervous system where these induce anesthesia.
The number of surgeries performed has increased across the globe,
including orthopedic, cardiovascular, cosmetic, and general
surgeries. According to the World Health Organization, the number of
surgical procedures performed in 2012 were 312.9 million as against
226.4 million in 2004, reflecting growth of 38.2%. This trend is
projected to continue due to increasing prevalence of chronic
diseases, health care expenditure, improving health care
infrastructure, and technological advancements. Increasing number of
surgeries performed is likely to drive consumption of inhalation
anesthetics during the forecast period. Inhalation anesthetics offer
shorter induction and recovery time, better efficiency, and less
interactions with other medications being administered to patient.
Inhalation anesthetics in conjugation with intravenous and other
anesthetic agents offer better anesthetic effect during surgical
procedures. These factors are anticipated to drive the inhalation
anesthetics market during the forecast period. However, need of
expensive capital equipment and few adverse effects associated with
inhalation anesthetics such as decrease in blood pressure and airway
resistance are expected to hamper the growth of the inhalation
anesthetics market.
The global inhalation anesthetics market has been segmented based on
product, end-user, and region. In terms of product, the market has
been segmented into volatile liquid agents and gaseous agents. The
volatile liquid agents segment is sub-segmented into sevoflurane,
isoflurane, desoflurane, and others. The gaseous agents market is
further segmented into nitrous oxide, xenon and others. The gaseous
agents segment is likely to hold significant share of the global
market owing to usage as a conjugate catalyst in other anesthetic
agents such as injectable and oral. Based on end-user, the global
market has been segmented into hospitals, ambulatory surgical
centers, and others. The ambulatory surgical centers segment is
anticipated to witness strong growth during the forecast period owing
to increasing base of ambulatory surgical centers and increasing
number of surgeries performed in these centers.
Download Report Brochure @
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=30656
In terms of region, the global inhalation anesthetics market has been
segmented into North America, Europe, Asia Pacific, Latin America,
and Middle East & Africa. North America is estimated to hold a
significant share of the global market due to high adoption of
technology and well-established health care infrastructure. Moreover,
high number of surgeries performed in this region is likely to
contribute to North America’s largest share of the market. Europe
is expected to hold a significant share of the global market and
anticipated to witness strong growth during the forecast period.
Increasing health care expenditure by the private as well as public
sector and developing health care infrastructure in Central and
Eastern Europe are projected to propel the market. Improving health
care infrastructure and large number of surgeries performed in
countries in Asia such as China, India, and Southeast Asia are
projected to propel the inhalation anesthetics market in Asia Pacific
during the forecast period.
Major players operating in the global inhalation anesthetics market
include Baxter International, Inc., AbbVie, Inc., Halocarbon Products
Corporation, Hikma Pharmaceuticals, Piramal Healthcare, Lunan
Pharmaceuticals, Mylan NV, Maruishi Pharmaceuticals Co. Ltd., Jiangsu
Hengrui Medicine Co., Ltd., Neon Laboratories Ltd., and Troikaa
Pharmaceuticals Ltd.
Pre-Book Full Report @
https://www.transparencymarketresearch.com/checkout.php?rep_id=30656<ype=S
About Us
Transparency Market Research (TMR) is a market intelligence company,
providing global business information reports and services. Our
exclusive blend of quantitative forecasting and trends analysis
provides forward-looking insight for thousands of decision makers.
TMR’s experienced team of analysts, researchers, and consultants,
use proprietary data sources and various tools and techniques to
gather, and analyze information. Our business offerings represent the
latest and the most reliable information indispensable for businesses
to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such
as pharmaceuticals, chemicals, energy, food & beverages,
semiconductors, med-devices, consumer goods and technology. These
reports provide in-depth analysis and deep segmentation to possible
micro levels. With wider scope and stratified research methodology,
TMR’s syndicated reports strive to provide clients to serve their
overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
Website:
https://www.transparencymarketresearch.com
No comments:
Post a Comment